These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35642021)

  • 1. Nitric-Oxide Synthase trafficking inducer (NOSTRIN) is an emerging negative regulator of colon cancer progression.
    Paul M; Gope TK; Das P; Ain R
    BMC Cancer; 2022 May; 22(1):594. PubMed ID: 35642021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric-oxide synthase trafficking inducer is a pleiotropic regulator of endothelial cell function and signaling.
    Chakraborty S; Ain R
    J Biol Chem; 2017 Apr; 292(16):6600-6620. PubMed ID: 28235804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial Nitric Oxide Synthase Traffic Inducer (NOSTRIN) is a Negative Regulator of Disease Aggressiveness in Pancreatic Cancer.
    Wang J; Yang S; He P; Schetter AJ; Gaedcke J; Ghadimi BM; Ried T; Yfantis HG; Lee DH; Gaida MM; Hanna N; Alexander HR; Hussain SP
    Clin Cancer Res; 2016 Dec; 22(24):5992-6001. PubMed ID: 27401251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L1-mediated colon cancer cell metastasis does not require changes in EMT and cancer stem cell markers.
    Gavert N; Vivanti A; Hazin J; Brabletz T; Ben-Ze'ev A
    Mol Cancer Res; 2011 Jan; 9(1):14-24. PubMed ID: 21123622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NOSTRIN: A novel modulator of trophoblast giant cell differentiation.
    Chakraborty S; Ain R
    Stem Cell Res; 2018 Aug; 31():135-146. PubMed ID: 30086473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintenance of the stemness in CD44(+) HCT-15 and HCT-116 human colon cancer cells requires miR-203 suppression.
    Ju SY; Chiou SH; Su Y
    Stem Cell Res; 2014 Jan; 12(1):86-100. PubMed ID: 24145190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Special AT-rich sequence-binding protein 2 acts as a negative regulator of stemness in colorectal cancer cells.
    Li Y; Liu YH; Hu YY; Chen L; Li JM
    World J Gastroenterol; 2016 Oct; 22(38):8528-8539. PubMed ID: 27784965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Claudin-7 expression induces mesenchymal to epithelial transformation (MET) to inhibit colon tumorigenesis.
    Bhat AA; Pope JL; Smith JJ; Ahmad R; Chen X; Washington MK; Beauchamp RD; Singh AB; Dhawan P
    Oncogene; 2015 Aug; 34(35):4570-80. PubMed ID: 25500541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer.
    Hu JL; Wang W; Lan XL; Zeng ZC; Liang YS; Yan YR; Song FY; Wang FF; Zhu XH; Liao WJ; Liao WT; Ding YQ; Liang L
    Mol Cancer; 2019 May; 18(1):91. PubMed ID: 31064356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-10a promotes epithelial-to-mesenchymal transition and stemness maintenance of pancreatic cancer stem cells via upregulating the Hippo signaling pathway through WWC2 inhibition.
    Wang C; Yin W; Liu H
    J Cell Biochem; 2020 Nov; 121(11):4505-4521. PubMed ID: 32542845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bmi-1 promotes the invasion and migration of colon cancer stem cells through the downregulation of E-cadherin.
    Zhang Z; Bu X; Chen H; Wang Q; Sha W
    Int J Mol Med; 2016 Oct; 38(4):1199-207. PubMed ID: 27600678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SNAIL regulates interleukin-8 expression, stem cell-like activity, and tumorigenicity of human colorectal carcinoma cells.
    Hwang WL; Yang MH; Tsai ML; Lan HY; Su SH; Chang SC; Teng HW; Yang SH; Lan YT; Chiou SH; Wang HW
    Gastroenterology; 2011 Jul; 141(1):279-91, 291.e1-5. PubMed ID: 21640118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMGA1 induces intestinal polyposis in transgenic mice and drives tumor progression and stem cell properties in colon cancer cells.
    Belton A; Gabrovsky A; Bae YK; Reeves R; Iacobuzio-Donahue C; Huso DL; Resar LM
    PLoS One; 2012; 7(1):e30034. PubMed ID: 22276142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doublecortin-Like Kinase 1 (DCLK1) Regulates B Cell-Specific Moloney Murine Leukemia Virus Insertion Site 1 (Bmi-1) and is Associated with Metastasis and Prognosis in Pancreatic Cancer.
    Li J; Wang Y; Ge J; Li W; Yin L; Zhao Z; Liu S; Qin H; Yang J; Wang L; Ni B; Liu Y; Wang H
    Cell Physiol Biochem; 2018; 51(1):262-277. PubMed ID: 30453285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA TUG1 promoted KIAA1199 expression via miR-600 to accelerate cell metastasis and epithelial-mesenchymal transition in colorectal cancer.
    Sun J; Hu J; Wang G; Yang Z; Zhao C; Zhang X; Wang J
    J Exp Clin Cancer Res; 2018 May; 37(1):106. PubMed ID: 29776371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-1β promotes stemness and invasiveness of colon cancer cells through Zeb1 activation.
    Li Y; Wang L; Pappan L; Galliher-Beckley A; Shi J
    Mol Cancer; 2012 Nov; 11():87. PubMed ID: 23174018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Notch-1 induces epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells.
    Bao B; Wang Z; Ali S; Kong D; Li Y; Ahmad A; Banerjee S; Azmi AS; Miele L; Sarkar FH
    Cancer Lett; 2011 Aug; 307(1):26-36. PubMed ID: 21463919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BMAL1 Knockdown Leans Epithelial-Mesenchymal Balance toward Epithelial Properties and Decreases the Chemoresistance of Colon Carcinoma Cells.
    Zhang Y; Devocelle A; Desterke C; de Souza LEB; Hadadi É; Acloque H; Foudi A; Xiang Y; Ballesta A; Chang Y; Giron-Michel J
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NOSTRIN: a protein modulating nitric oxide release and subcellular distribution of endothelial nitric oxide synthase.
    Zimmermann K; Opitz N; Dedio J; Renne C; Muller-Esterl W; Oess S
    Proc Natl Acad Sci U S A; 2002 Dec; 99(26):17167-72. PubMed ID: 12446846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GRHL2 inhibits colorectal cancer progression and metastasis via oppressing epithelial-mesenchymal transition.
    Yang Z; Wu D; Chen Y; Min Z; Quan Y
    Cancer Biol Ther; 2019; 20(9):1195-1205. PubMed ID: 31063022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.